The Development of Vaccines from Synthetic Tumor-Associated Mucin Glycopeptides and their Glycosylation-Dependent Immune Response.

Stergiou, Natascha; Urschbach, Moritz; Gabba, Adele; Schmitt, Edgar; Kunz, Horst; Besenius, Pol

Stergiou, Natascha; Urschbach, Moritz; Gabba, Adele; Schmitt, Edgar; Kunz, Horst; Besenius, Pol.

Afiliação

Stergiou N; Radionuclide Center, Radiology and Nuclear medicine Amsterdam UMC, VU University, De Boelelaan 1085c, 1081 HV, Amsterdam, the Netherlands.
Urschbach M; Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128, Mainz, Germany.
Gabba A; Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128, Mainz, Germany.
Schmitt E; Institute of Immunology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Kunz H; Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128, Mainz, Germany.
Besenius P; Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128, Mainz, Germany.

Chem Rec ; 21(11): 3313-3331, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34812564

Assuntos

Vacinas Anticâncer; Glicopeptídeos; Mucinas/imunologia; Neoplasias/prevenção & controle; Vacinas Anticâncer/imunologia; Glicosilação; Humanos; Imunidade; Neoplasias/imunologia; Vacinas Sintéticas

Palavras-chave

Immunotherapy; anti-tumor vaccines; glycoconjugate; glycopeptide antigens; subunit vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicopeptídeos / Vacinas Anticâncer / Mucinas / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Chem Rec Assunto da revista: QUIMICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google